Development of serotonin transporter reuptake inhibition assays using JAR cells
- 1 July 2018
- journal article
- research article
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 92, 52-56
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R03DA036208)
This publication has 28 references indexed in Scilit:
- Mitochondrial Complex I Inhibitor Rotenone Inhibits and Redistributes Vesicular Monoamine Transporter 2 via Nitration in Human Dopaminergic SH-SY5Y CellsMolecular Pharmacology, 2008
- Lobeline effects on tonic and methamphetamine-induced dopamine releaseBiochemical Pharmacology, 2008
- New Insights into the Mechanism of Action of AmphetaminesAnnual Review of Pharmacology and Toxicology, 2007
- Serotonin transporters: Implications for antidepressant drug developmentThe AAPS Journal, 2005
- Mechanisms of neurotransmitter release by amphetamines: A reviewProgress in Neurobiology, 2005
- Parkin Increases Dopamine Uptake by Enhancing the Cell Surface Expression of Dopamine TransporterJournal of Biological Chemistry, 2004
- Functional expression of the plasma membrane serotonin transporter but not the vesicular monoamine transporter in human placental trophoblasts and choriocarcinoma cellsPlacenta, 1996
- Identification of a GBR12935 homolog, LR1111, which is over 4,000‐fold selective for the dopamine transporter, relative to serotonin and norepinephrine transportersSynapse, 1993
- Neurotransmitter Transporters: Recent ProgressAnnual Review of Neuroscience, 1993
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973